The drug has been approved in the United States in November 2016 and in Europe under the brand name Xultrophy
Genetic data should be interpreted with your provider alongside clinical history, biomarkers, and lifestyle factors to support a personalized treatment discussion
FIP1L1/PDGFRalpha synergizes with SCF to induce systemic mastocytosis in a murine model of chronic eosinophilic leukemia/hypereosinophilic syndrome
It has not been previewed, commissioned or otherwise endorsed by any of our network partners.
It often happens after initial improvements from diet and lifestyle changes, leaving you wondering what youre missing
In moderate doses, some studies suggest that the tea may have helpful effects on cholesterol, weight loss, the heart, inflammation, diabetes, and cancer risk